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Abstract
Background: Incisional hernias are common complications of midline closure following abdominal surgery and
cause significant morbidity, impaired quality of life and increased health care costs.
The ‘Hughes Repair’ combines a standard mass closure with a series of horizontal and two vertical mattress sutures
within a single suture. This theoretically distributes the load along the incision length as well as across it. There is
evidence to suggest that this technique is as effective as mesh repair for the operative management of incisional
hernias; however, no trials have compared the Hughes Repair with standard mass closure for the prevention of
incisional hernia formation following a midline incision.
Methods/design: This is a 1:1 randomised controlled trial comparing two suture techniques for the closure of the
midline abdominal wound following surgery for colorectal cancer. Full ethical approval has been gained (Wales REC 3,
MREC 12/WA/0374). Eight hundred patients will be randomised from approximately 20 general surgical units within
the United Kingdom. Patients undergoing open or laparoscopic (more than a 5-cm midline incision) surgery for
colorectal cancer, elective or emergency, are eligible. Patients under the age of 18 years, those having mesh inserted or
undergoing musculofascial flap closure of the perineal defect in abdominoperineal wound closure, and those unable
to give informed consent will be excluded. Patients will be randomised intraoperatively to either the Hughes Repair or
standard mass closure. The primary outcome measure is the incidence of incisional hernias at 1 year as assessed by
standardised clinical examination. The secondary outcomes include quality of life patient-reported outcome measures,
cost-utility analysis, incidence of complete abdominal wound dehiscence and C-POSSUM scores. The incidence of
incisional hernia at 1 year, assessed by computerised tomography, will form a tertiary outcome.
Discussion: A feasibility phase has been completed. The results of the study will be used to inform current and future
practice and potentially reduce the risk of incisional hernia formation following midline incisions.
Trial registration: Trial Registration Number: ISRCTN 25616490. Registered on 1 January 2012.
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Background
Incisional hernias (IHs) are ‘abdominal wall gaps around
postoperative scars, perceptible or palpable by clinical
examination or imaging’ [1, 2]. They are common compli-
cations of midline closure following major abdominal sur-
gery and cause significant morbidity, impaired quality of life
(QoL) [3] and increased cost [4]. The standard technique
for abdominal closure is ‘mass closure’ (closing all layers of
the abdominal wall, excluding the skin), usually with non-
absorbable sutures, although ‘slow-resorbing’ sutures such
as polydioxanone (PDS) are also widely used [5].
The reported incidence of IHs ranges widely; from 8.6
to 33 % following open colorectal surgery, and from 4.7 to
24.3 % following laparoscopic colorectal surgery [6–9].
The long-term results of IH repair are disappointing. The
two main surgical options for fixing these hernias are su-
ture repair or mesh repair (suture closure reinforced by a
synthetic mesh), yet recurrence rates are as high as 12 to
54 % and 2 to 36 %, respectively [10, 11]. IH repair may
also lead to serious complications such as enterocuta-
neous fistulae, bowel obstruction or chronic pain, which
have an even greater impact on QoL. Given such disap-
pointing results from corrective surgery, the search for
preventative measures is important.
Many factors contribute to the pathogenesis of IHs;
these include diabetes mellitus [12], obesity [12, 13],
cachexia [14], aged older than 45 years [13], male sex
[13, 15], history of chronic obstructive pulmonary dis-
ease (COPD) [14, 16] post-menopausal status [17], his-
tory of abdominal aortic aneurysm [18], anaemia [14],
history of smoking [15] and certain medications (e.g.
corticosteroids) [19]. Most of these are outside the sur-
geons’ control and the only modifiable factors identified
as having a substantial impact on IH rates are the surgi-
cal technique and the material used to close the abdom-
inal wall musculofascial layer.
There have been many studies to identify the best
technique for abdominal wall closure, yet there is still
uncertainty about this. For example, the meta-analyses
by Hodgson et al. [20], van’t Riet et al. [11] and Weiland
et al. [21] concluded that nonabsorbable sutures reduce
IH risk, whilst the more recent meta-analysis by Diener
et al. [10] showed that absorbable sutures were associ-
ated with a lower risk. Such a discrepancy may be due in
part to different inclusion or exclusion criteria. Further-
more, most studies included in these meta-analyses re-
cruited small numbers of patients and lacked sufficient
power to detect statistically significant differences be-
tween groups [10]. More recent work has focussed on
different techniques used to close the abdominal wall.
The STITCH trial [22], a Dutch multicentre, randomised
controlled trial (RCT) that has reported its outcomes for
560 patients comparing small-stitch continuous sutures
with (large-stitch) standard mass closure. They found a
reduction from 21 % (large-bite) to 13 % (small-bite) in
the rate of IHs at 1 year. The CONTinuous versus
INTerrupted abdominal wall closure after emergency
midline laparotomy (CONTINT) RCT, still recruiting, is
comparing continuous with interrupted sutures in clos-
ing midline incisions after emergency laparotomy [23].
Hughes Repair
The eponymously titled ‘Hughes Repair’ (Professor Leslie
Hughes, 1932–2011 [24]), also known as the ‘far-and-near’
or ‘Cardiff Repair’ [25] combines a standard mass closure
(two loop 1-PDS sutures) with a series of horizontal and
two vertical mattress sutures within a single suture (1
Nylon); theoretically distributing the load along the inci-
sion length as well as across it (Fig. 1). The principles are:
1. To ensure, by palpation, that only sound normal
tissues are used for the repair
2. To use graduated tension for easy approximation
3. Use a monofilament Nylon suture, which has the
advantage of slipping easily through tissues to create
a pulley system [26]
The Hughes Repair has been demonstrated to be as ef-
fective as the standard mesh repair in treating patients
with IHs [27]. It is also used for closing abdomens when
patients are at high risk of IHs, after complete abdom-
inal wound dehiscence and laparostomy [28]. This trial
aims to ascertain if this technique can be used as pri-
mary prevention for IH formation. In addition it will
provide valuable information on the aetiology of IH with
an objective, radiological assessment of their formation.
Methods/design
Primary outcome
The primary outcome measure is to the incidence of IHs
at 1 year from colorectal cancer surgery between the
Hughes Repair and standard mass closure as assessed by
clinical examination.
Secondary outcomes
The secondary outcomes include:
 To compare QoL over 1 year between the Hughes
Repair and standard mass closure (the Functional
Assessment of Cancer Therapy-Colorectal
(FACT-C) and the 12-Item Short-Form Health
Survey (SF12))
 To evaluate the cost-effectiveness of the Hughes
Repair relative to standard mass closure over the
first year (using the Client Service Receipt
Inventory)
 To test whether the Hughes Repair reduces the
incidence of postoperative complete abdominal
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wound dehiscence between the Hughes Repair and
standard mass closure by day 30
 To identify and characterise patient and surgical
factors which increase the risk of developing IHs
 To estimate the prevalence of IHs at 1 year
following surgery for colorectal cancer in patients
receiving the Hughes Repair or standard mass
closure
Tertiary outcome
 To assess the incidence of IH at 1 year by
computerised tomography (CT) scanning and
compare to the clinical assessment
Primary hypothesis
The Hughes Repair results in a reduced incidence of IH at
1 year in patients having midline abdominal wall closure
incisions following elective or emergency colorectal cancer
surgery when compared with standard mass closure.
Study design
This is a multicentre, blinded, RCT (Fig. 2).
Study population
The study will identify patients who are due to receive
abdominal surgery for the treatment of colorectal can-
cer. Patients undergoing emergency surgical treatment
as well as patients receiving elective surgical treatment
will be eligible for inclusion.
Setting
The study is being performed in general surgical units
within the NHS across the United Kingdom, aiming for
recruitment from at least 20 sites. Informed consent will
be obtained from all patients. This study has ethical ap-
proval from Wales REC 3 (MREC 12/WA/0374). A full
list of current approvals is appended.
Eligibility criteria
Inclusion criteria
At screening:
 Patients aged 18 years or older
 Able to give informed consent
 Both standard mass closure and the Hughes Repair
closure are suitable closing techniques for the
patient
 An elective patient for colorectal cancer surgery
following full staging investigations including an
abdominal CT scan or an emergency patient with a
strong suspicion of colorectal cancer as per CT
At point of surgical closure/randomisation:
 Midline abdominal incision (open or laparoscopic
assisted/converted)
 Incision of 5 cm or more
Exclusion criteria
At screening:
 Unable to provide informed consent
At point of surgical closure/randomisation:
 Inserting a mesh as part of abdominal closure
 Undergoing musculofascial flap closure of perineal
defect in abdominoperineal wound closure
Outcome assessment
Primary outcome
The primary outcome is the incidence of IHs over 1 year
as assessed by clinical examination of the abdomen. The
clinical presence of a hernia will be assessed either by a
surgeon or a nurse specialist who has received clinical
examination training as part of their role. The presence
of a hernia can be detected as a reducible, palpable mass,
usually with a cough impulse, which may cause the
Fig. 1 Diagram showing the Hughes closure method, using a combination of standard mass closure with a series of horizontal and two vertical
mattress sutures within a single suture. When the sutures are pulled to close the defect, the sutures lie both across and along the incision
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patient discomfort or pain. The examiner will assess the
patient ensuring to include the following:
 With the patient in a standing position, palpate the
length of the closed wound and ask the patient to
cough or perform the Valsalva manoeuvre
 With the patient in a supine position, palpate the
length of the closed wound and ask the patient to
cough or perform the Valsalva manoeuvre
Secondary outcome
The following secondary outcomes will be assessed:
 Two QoL Patient-reported Outcome Measures
(PROMs) will be administered at baseline, 30 days,
6 months and 1 year to assess the differences
between the two trial groups. The questionnaires
used will be SF12 [29] and the FACT-C [30]
 Cost-utility analysis of the Hughes Repair in relation
to the mass closure from the perspective of the NHS
will be undertaken
 Data on the incidence of full-thickness abdominal
wall dehiscence will be collected up to 30 days post
operation, as well as details of any repair surgery
and the closing sutures used
 Data will be collected regarding patient conditions
that are considered to be associated with an
increased risk of developing hernias. Colorectal –
Physiological and Operative Severity Score for
Understanding Mortality and Morbidity
(C-POSSUM) scores [31] to assess risk of mortality
and morbidity in patients undergoing colorectal
surgery will also be completed. Data will be
collected for patients developing SSIs (surgical site
infections) in hospital; the SSIs will be classified into
superficial, deep (involving muscle or fascia) or
confined to an organ or space [32]
 The prevalence of IHs at 1 year as measured by
clinical examination will be assessed. PROMs will be
administered at baseline, 30 days, 6 months and
1 year
 The QoL of patients with or without IHs will be
compared over 1 year. PROMs will be administered
at baseline, 30 days, 6 months and 1 year to assess
the differences between the two groups
Sample size estimation
The study aims to detect a reduction in IH rates from
30 % for mass closure to 20 % for the Hughes Repair. To
give 80 % power of detecting this difference with a 5 %
significance level requires 640 patients to be followed up
for 1 year. As loss to follow-up from similar trials [33] is
about 20 % at 1 year, HART aims to recruit 800 patients
in total.
Discussion
Study process
After screening, consent and surgery, each participant
will attend two separate visits (at 30 days and 6 months)
during the first year (these may be conducted by tele-
phone if required) and undergo a CT scan and clinical
examination at 1 year post surgery. Data collected at the
1-year visit will support the primary endpoint.
Randomisation
An adaptive randomisation design will be used to allocate
eligible patients to groups of similar size [34]. Telephone
randomisation will be accessed by the closing surgeon and
will take place during surgery and as close as possible to
the time when the surgeon commences closure.
Data management
This data management aspect of the study is being
supported by the Swansea Trials Unit (STU). Data will
be collected using an electronic data capture system
(MACRO 4).
Training in closure techniques
To assure the quality of the repair techniques, all surgeons
participating in the trial (consultants and trainees) will
complete training and quality assessment on the Hughes
Repair. All participating surgeons will be assessed by the
chief investigator or a designated assessor and approved
only when closure technique is satisfactory. A reference
instructional video will also be provided as well as ongoing
quality review of the technique throughout the course of
Fig. 2 Hughes Abdominal Repair Trial (HART) study design
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the trial. To monitor the training of professionals con-
tributing to HART, a log will be maintained at each site
with details of training, both surgical and in research
governance notably Good Clinical Practice (GCP). For the
purposes of the study mass closure will be taken to
be the responsible consultant surgeon’s standard
closure technique (Additional file 1).
Radiological evaluation of incisional hernia
Dedicated trial radiologists will determine whether there
is a hernia present, define it as herniation of the bowel
or other intra-abdominal content outside the abdominal
wall, and identify the presence of other hernias and the
quality of the recti muscle.
CT imaging
Scans should be acquired using the thinnest slice thick-
ness capability of the scanner and images for review re-
constructed to 5-mm or 2.5-mm slice thickness in the
axial plane. Scans should be done using the standard de-
partmental protocol for staging and follow-up scans.
Transfer of CT images
The transfer of CT images from participating site to
reviewing radiologists will be done using the Picture
Archiving and Communications System (PACS) or equiva-
lent. Relevant images will be requested of the study team at
site on a regular basis.
Management and safety
Documentation will be put in place to describe all key
processes (governed by STU Standard Operating Proce-
dures (SOPs)). The Trial Management Group (TMG),
including patient and public representatives, will meet
every month with audio facilities for site principal inves-
tigators. Protocol deviations and adverse events will be
monitored by STU, regularly reported to the TMG with
the clinical chief investigator taking overall responsibility,
and formally reporting to the Data Monitoring Committee
(DMC). Both the DMC and the Trial Steering Committee
(TSC) will meet regularly to monitor progress.
Data analysis
Data analysis will follow the principles outlined in the
Statistical Analysis Plan (SAP), which covers both clinical
and cost-effectiveness analyses. Specifically, analyses, by
‘treatment allocated’, will adjust for significant factors and
covariates, and use an NHS perspective on costs, assessed
via incremental cost-effectiveness ratios (ICERs). The
DMC will be asked to review and comment on this inte-
grated plan, and to approve it prior to any analysis of the
data. Analysts, who should remain blinded until the TSC
deem otherwise, will then undertake a single main analysis
at the end of the trial when all 1-year visits have been
completed.
Trial status
Ethical considerations
This study complies with the World Medical Association
Declaration of Helsinki (2013) and the principles of GCP.
CT scans at years 1 and 2 are required as part of standard
care and, therefore, compliance with IRMER approval is
in place. The study will respect the rights of participating
patients and ensure confidentiality of patient information.
Patients undergoing surgery for colorectal cancer have an
excellent support system through the specialist cancer
nurses and the clinical team, as well as several charities
and voluntary organisations. Should participants have
additional questions about the trial, advice will be available
from both within the research team and outside of the re-
search team in the form of websites such as the NHS web-
site page: Clinical trials and medical research – Joining a
trial, found on http://www.nhs.uk/Conditions/Clinical-
trials/Pages/Takingpart.aspx.
Current status
The trial is split into three phases, a feasibility, pilot and
main study phase. The feasibility phase of 30 patients at
the host site has been completed. Data from this part of
the study will not be included in the final analysis. The
pilot phase of the study of 80 patients is complete and
with no safety issues identified following review by the
DMC the main study is ongoing with further sites open-
ing now.
Additional file
Additional file 1: SPIRIT figure_HARTR1. (DOCX 16 kb)
Abbreviations
CONTINT: CONTinuous versus INTerrupted abdominal wall closure after
emergency midline laparotomy; COPD: Chronic obstructive pulmonary
disease; C-POSSUM: Colorectal – Physiological and Operative Severity Score
for Understanding Mortality and Morbidity; CT: Computed tomography;
DMC: Data Monitoring Committee; FACT-C: Functional Analysis of Cancer
Therapy – Colorectal; GCP: Good Clinical Practice; HART: Hughes Abdominal
Repair Trial; ICER: Incremental cost-effectiveness ratios; IH: Incisional hernia;
IRMER: Ionising radiation (Medical Exposure) regulations 2000; NHS: National
health service; PACS: Picture Archiving and Communications System;
PDS: polydioxanone; PI: Principal investigator; PROMs: Patient-reported
Outcome Measures; QoL: Quality of life; REC: Research Ethics Committee;
SAP: Statistical Analysis Plan; SCTU: Swansea Clinical Trials Unit; SF12 or
SF36: Short Form 12 or 36 (quality of life questionnaires); SSI: surgical site
infection; STITCH: Suture Techniques to reduce the Incidence of The
inCisional Hernia (RCT); TSC: Trial Steering Committee; TMG: Trial
Management Group
Authors’ contributions
AB-S aided in redrafting and revising the protocol and contributed heavily to
completion of the feasibility trial and pilot stages. AW helped to write the
analysis plan and revised the protocol. BR helped to design and draft the
original protocol. CM aided in redrafting and revising the protocol and
Cornish et al. Trials  (2016) 17:454 Page 5 of 6
contributed heavily to completion of the feasibility trial and pilot stages.
CP and ZD aided in redrafting and revising the protocol and contributed
heavily to completion of the feasibility trial and pilot stages. DB helped to
design and draft the original protocol and helped to write the funding
application. DHarris aided in redrafting and revising the protocol and
contributed heavily to completion of the feasibility trial and pilot stages.
IR helped to design and draft the original protocol, helped to write the
funding application and wrote and designed the analysis plan and revised
the protocol. JA helped to draft the original protocol. JC conceived,
designed and drafted the initial protocol and helped to lead the team that
acquired the funding. JH aided in redrafting and revising the protocol and
contributed heavily to completion of the feasibility trial and pilot stages.
JT conceived, designed and drafted the initial protocol and also led the
team that acquired the funding. NB helped to write the analysis plan and
revised the protocol. NF helped to design and draft the original protocol.
MLD aided in redrafting and revising the protocol and contributed heavily
to completion of the feasibility trial and pilot stages. MMD and DHanratty
aided in redrafting and revising the protocol and contributed heavily to
completion of the feasibility trial and pilot stages. PDR aided in redrafting
and revising the protocol and contributed heavily to completion of the
feasibility trial and pilot stages. REO aided in redrafting and revising the
protocol and contributed heavily to completion of the feasibility trial and
pilot stages. RH helped to draft the original protocol. RR and JH aided in
redrafting and revising the protocol and contributed heavily to completion
of the feasibility trial and pilot stages. SI helped to write and designed the
analysis plan and revised the protocol. SJ aided in redrafting and revising the
protocol and contributed heavily to completion of the feasibility trial and
pilot stages. SP aided in redrafting and revising the protocol and contributed
heavily to completion of the feasibility trial and pilot stages. All authors
agree to be accountable for all aspects of the work. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Author details
1Department of Surgery, University Hospital of Wales, Heath Park, Cardiff
CF14 4XW, UK. 2Princess of Wales Hospital, Bridgend, UK. 3Morriston Hospital,
Swansea, UK. 4Wrexham Maelor Hospital, Wrexham, UK. 5Glan Clwyd
Hospital, Rhyl, UK. 6Royal Glamorgan Hospital, Llantrisant, UK. 7Swansea
Clinical Trials Unit, Swansea University, Swansea, UK. 8Involving People,
Health and Care Research Wales, Cardiff, UK.
Received: 22 February 2016 Accepted: 14 August 2016
References
1. Korenkov M, Paul A, Sauerland S, et al. Classification and surgical treatment
of incisional hernia. Results of an experts’ meeting. Langenbecks Arch Surg.
2001;386(1):65–73.
2. Muysoms FE, Miserez M, Berrevoet F, et al. Classification of primary and
incisional abdominal wall hernias. Hernia. 2009;13(4):407–14.
3. van Ramshorst GH, Eker HH, Hop WC, et al. Impact of incisional hernia on
health-related quality of life and body image: a prospective cohort study.
Am J Surg. 2012;204(2):144–50.
4. Burger JW, Luijendijk RW, Hop WC, et al. Long-term follow-up of a
randomized controlled trial of suture versus mesh repair of incisional hernia.
Ann Surg. 2004;240(4):578–83.
5. Sajid MS, Parampalli U, Baig MK, McFall MR. A systematic review on the
effectiveness of slowly-absorbable versus non-absorbable sutures for
abdominal fascial closure following laparotomy. Int J Surg. 2011;9(8):615–25.
6. Braga M, Frasson M, Vignali A, et al. Laparoscopic vs. open colectomy in
cancer patients: long-term complications, quality of life, and survival. Dis
Colon Rectum. 2005;48(12):2217–23.
7. Kuhry E, Schwenk W, Gaupset R, et al. Long-term outcome of laparoscopic
surgery for colorectal cancer: a Cochrane systematic review of randomised
controlled trials. Cancer Treat Rev. 2008;34(6):498–504.
8. Skipworth JR, Khan Y, Motson RW, et al. Incisional hernia rates following
laparoscopic colorectal resection. Int J Surg. 2010;8(6):470–3.
9. Winslow ER, Fleshman JW, Birnbaum EH, Brunt LM. Wound complications of
laparoscopic vs open colectomy. Surg Endosc. 2002;16(10):1420–5.
10. Diener MK, Voss S, Jensen K, et al. Elective midline laparotomy closure: the
INLINE systematic review and meta-analysis. Ann Surg. 2010;251(5):843–56.
11. van’t Riet M, Steyerberg EW, Nellensteyn J, et al. Meta-analysis of techniques
for closure of midline abdominal incisions. Br J Surg. 2002;89(11):1350–6.
12. Franchi M, Ghezzi F, Buttarelli M, et al. Incisional hernia in gynecologic
oncology patients: a 10-year study. Obstet Gynecol. 2001;97(5 pt 1):696–700.
13. Hoer J, Lawong G, Klinge U, Schumpelick V. Factors influencing the
development of incisional hernia. A retrospective study of 2,983 laparotomy
patients over a period of 10 years. Chirurg. 2002;73(5):474–80.
14. Mäkelä JT, Kiviniemi H, Juvonen T, Laitinen S. Factors influencing wound
dehiscence after midline laparotomy. Am J Surg. 1995;170(4):387–90.
15. Sørensen LT, Hemmingsen UB, Kirkeby LT, et al. Smoking is a risk factor for
incisional hernia. Arch Surg. 2005;140(2):119–23.
16. Adell-Carceller R, Segarra-Soria MA, Pellicer-Castell V, et al. Incisional hernia
in colorectal cancer surgery. Associated risk factors. Cir Esp. 2006;79(1):42–5.
17. Colombo M, Maggioni A, Parma G, et al. A randomized comparison of
continuous versus interrupted mass closure of midline incisions in patients
with gynecologic cancer. Obstet Gynecol. 1997;89(5 pt 1):684–9.
18. Adye B, Luna G. Incidence of abdominal wall hernia in aortic surgery.
Am J Surg. 1998;175(5):400–2.
19. Junge K, Klinge U, Klosterhalfen B, et al. Review of wound healing
with reference to an unrepairable abdominal hernia. Eur J Surg.
2002;168(2):67–73.
20. Hodgson NC, Malthaner RA, Ostbye T. The search for an ideal method of
abdominal fascial closure: a meta-analysis. Ann Surg. 2000;231(3):436–42.
21. Weiland DE, Bay RC, Del Sordi S. Choosing the best abdominal closure by
meta-analysis. Am J Surg. 1998;176(6):666–70.
22. Deerenberg EB, Harlaar JJ, Steyerberg EW, et al. Small bites versus large
bites for closure of abdominal midline incisions (STITCH): a double-blind,
multicentre, randomised controlled trial. Lancet. 2015. Epub. http://dx.doi.
org/10.1016/S0140-6736(15)60459-7.
23. Rahbari NN, Knebel P, Kieser M, et al. Design and current status of CONTINT:
continuous versus interrupted abdominal wall closure after emergency
midline laparotomy— a randomized controlled multicenter trial
[NCT00544583]. Trials. 2012;13:72.
24. Hughes BR, Webster D. Leslie Ernest Hughes – Obituary. BMJ. 2011;343.
25. Shukla VK, Gupta A, Singh H, et al. Cardiff repair of incisional hernia: a
university hospital experience. Eur J Surg. 1998;164(4):271–4.
26. Mudge M, Harding KG, Hughes LE. Incisional hernia. Br J Surg. 1986;73(1):82.
27. Godara R, Garg P, Shankar G. Comparative evaluation of Cardiff repair and
mesh plasty in incisional hernias. Internet J Surg [Internet]. 2007;9:about 8 p.
Available from: http://www.ispub.com/journal/the_internet_journal_of_
surgery/volume_9_number_1/article/comparative_evaluation_of_cardiff_
repair_and_mesh_plasty_in_incisional_hernias.html.
28. Malik R, Scott NA. Double near and far prolene suture closure: a technique
for abdominal wall closure after laparostomy. Br J Surg. 2001;88(1):146–7.
29. Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity.
Med Care. 1996;34(3):220–33.
30. Ward WL, Hahn EA, Mo F, et al. Reliability and validity of the Functional
Assessment of Cancer Therapy-Colorectal (FACT-C) quality of life instrument.
Qual Life Res. 1999;8(3):181–95.
31. Tekkis PP, Prytherch DR, Kocher HM, et al. Development of a dedicated
risk-adjustment scoring system for colorectal surgery (colorectal POSSUM).
Br J Surg. 2004;91(9):1174–82.
32. Murray BW, Cipher DJ, Pham T, Anthony T. The impact of surgical site
infection on the development of incisional hernia and small bowel
obstruction in colorectal surgery. Am J Surg. 2011;202(5):558–60.
33. Russell IT, Attwood S, Barr H, et al. Cancer of oesophagus or gastricus—new
assessment of technology of endosonography: findings. J Epidemiol
Community Health. 2010;64 Suppl 1:A36–7.
34. Russell D, Hoare ZSJ, Whitaker R, Whitaker CJ, Russell IT. Generalized method
for adaptive randomization in clinical trials. Stat Med. 2011;30(9):922–34.
Cornish et al. Trials  (2016) 17:454 Page 6 of 6
